Clinical Trial Update: B7-H3 NIR Imaging for Osteosarcoma Surgery [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for a B7-H3-targeted near-infrared imaging probe to assist osteosarcoma surgery, spanning Phase 1 and Phase 2 and currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteosarcoma

Drugs mentioned

• B7-H3 NIR Imaging Probe (B7-H3 targeted near-infrared imaging probe)

Snippet

Sponsor: Peking University People's Hospital | Conditions: Osteosarcoma, Resection Margins | Phase 1, Phase 2 | Status: RECRUITING